Observational Prospective Evaluation of Factors Affecting Hospitalisation in Patients Undergoing EBUS-TBNA

November 10, 2026 updated by: İlker Onguc Aycan

In this study, the perioperative data of EBUS procedures, file information, and anesthesia records during the procedure were analyzed in relation to patient complication rates and the correlation of complications with patient profiles

Study Overview

Status

Completed

Conditions

Detailed Description

Many noninvasive and invasive methods are used for the evaluation of mediastinal masses and lymph nodes. Mediastinoscopy is the gold standard for evaluation. However, this procedure is invasive and requires hospitalisation. In addition, mediastinoscopy has some life-threatening complications such as mediastinal surgical bleeding, mediastinitis, pneumothorax and subcutaneous emphysema. Therefore, different minimally invasive methods have been tried. Endobronchial ultrasound has been accepted as a reliable procedure frequently used in preoperative nodal staging because it has similar diagnostic values compared to mediastinoscopy, low complication rates and is a less invasive method.

In this study, patients were evaluated in a wide range of scales. Preoperative pulmonary function tests, STOP-BANG/Charlson Comorbidity Index questionnaire scores, preoperative blood gas values, additional comorbidities, ASA and Body mass indexes, saturation values before the procedure, saturation values during the procedure and complications occurring during the procedure are discussed. In the light of this information, the factors affecting the post-procedure hospitalisations of the patients were evaluated comprehensively. In addition, the duration of PACU/ICU requirement of these patients was also compared according to these criteria. In addition to ASA scores, 4 main specialised ASA scores were performed in the patients: Cardiovascular, Renal, Liver and Central Nervous System ASA.

According to the data mentioned, patients were divided into two groups: those discharged home after the procedure and those requiring hospital admission. During the preoperative anesthesia consultation, patients' postoperative needs were assessed according to PACU/ICU requirements as planned or unplanned PACU/ICU/ward admissions. Complication rates were compared based on the procedure areas according to the Wang Map. For these patients, the time to exitus within 1 month and between 1 and 6 months post-procedure was also evaluated.

Preoperative values, including hemogram, electrolytes, BUN, creatinine, ALT, AST, INR, and APTT, were reviewed for the patients. The relationship between these values and the need for hospital admission post-procedure was examined.

Study Type

Observational

Enrollment (Actual)

241

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients over 18 years of age who underwent EBUS

Description

Inclusion Criteria:

  • Being over 18 years of age

Exclusion Criteria:

  • Emergency operations, those whose data cannot be accessed, those whose transactions are canceled during the procedure

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: CASE_ONLY
  • Time Perspectives: PROSPECTIVE

Cohorts and Interventions

Group / Cohort
dischared patients

Patients discharged after ebus procedure

Hospitalized patients

Patients who are admitted to the ward or PACU or ICU after the procedure

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hospitalization percentage
Time Frame: After the procedure

The percentage of patients admitted to the hospital ward, PACU (Post-Anesthesia Care Unit), or ICU (Intensive Care Unit).

After the procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complications
Time Frame: During or after the procedure

Postoperative complications such as desaturation, arrhythmia, minor bleeding, hypertansion, hypoxemia

During or after the procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2024

Primary Completion (Actual)

October 1, 2024

Study Completion (Actual)

November 10, 2024

Study Registration Dates

First Submitted

November 10, 2026

First Submitted That Met QC Criteria

November 10, 2026

First Posted (Actual)

November 16, 2026

Study Record Updates

Last Update Posted (Actual)

November 16, 2026

Last Update Submitted That Met QC Criteria

November 10, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • EBUS observational prospective

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.